The Chinese of Hong Kong | Hong Kong
Author Profile
Scopus
Orcid ID
EARLY ACADEMIC PURSUITS
Dr. Jingying Zhou commenced her academic journey by earning a Ph.D. in Microbiology from The University of Hong Kong (HKU) in 2013. Prior to her doctoral studies, she obtained an M.Phil. in Virology and Microbiology from Wuhan University in 2008, following a Bachelor of Science degree in Biology from the same university in 2005.
PROFESSIONAL ENDEAVORS
After completing her Ph.D., Dr. Zhou embarked on a productive period as a Postdoctoral Fellow at the School of Biomedical Sciences (SBS), CUHK, spanning from September 2013 to September 2018. Demonstrating her commitment to academic research, she then assumed the role of Research Assistant Professor at SBS, CUHK, where she continued to contribute significantly to the field until February 2022.
During her tenure as a Postdoctoral Fellow and Research Assistant Professor, Dr. Zhou delved into T cell-based immunotherapies in cancers. Her research explored the intricate dynamics of the liver microenvironment in the context of cancer metastasis and immunotherapy resistance. These efforts significantly contributed to the understanding of novel treatment modalities in cancer research.
IMPACT AND INFLUENCE
Dr. Zhou's work has had a noteworthy impact on the field, shaping the discourse on T cell-based immunotherapies and providing insights into the complexities of the liver microenvironment. Her research has garnered attention for its potential implications in addressing challenges related to cancer metastasis and immunotherapy resistance.
ACADEMIC CITATIONS
Dr. Zhou's work has likely served as a reference point for fellow researchers and clinicians working in the domain of cancer immunotherapy and microenvironment studies.
LEGACY AND FUTURE CONTRIBUTIONS
As of February 2022, Dr. Jingying Zhou holds the position of Assistant Professor at SBS, CUHK, marking the continuation of her academic journey. Her appointment to this role underscores her dedication to advancing knowledge in the field. Given her track record, it is anticipated that Dr. Zhou will leave a lasting legacy through her ongoing and future contributions to microbiology and cancer research.
Notable Publications
Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma 2023(11)
Isoformic PD-1-mediated immunosuppression underlies resistance to PD-1 blockade in hepatocellular carcinoma patients 2023(5)
Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma 2023(9)